Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,648 | -18,129 | -12,086 | -81,723 | -59,501 |
| Depreciation Amortization | 3,396 | 2,309 | 1,186 | 3,492 | 2,618 |
| Accounts receivable | -862 | -506 | 15 | -75 | N/A |
| Accounts payable and accrued liabilities | -4,353 | -4,989 | -4,648 | 2,555 | 914 |
| Other Working Capital | 1,155 | 8,782 | 19,960 | 5,718 | -4,678 |
| Other Operating Activity | 9,578 | 8,207 | 5,574 | 5,605 | 6,401 |
| Operating Cash Flow | $-14,736 | $-4,326 | $10,000 | $-64,428 | $-54,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,615 | -24,846 | 0 | 17,308 | 16,308 |
| PPE Investments | -7,811 | -6,653 | -5,297 | -3,860 | -1,148 |
| Investing Cash Flow | $-44,426 | $-31,499 | $-5,297 | $13,448 | $15,160 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -97 | -97 | -47 | -218 | -163 |
| Common Stock Issued | 12,692 | 12,692 | 12,500 | 55,984 | 2,285 |
| Other Financing Activity | -417 | -417 | -417 | -634 | -634 |
| Financing Cash Flow | $12,178 | $12,178 | $12,036 | $55,132 | $1,488 |
| Beginning Cash Position | 85,367 | 85,367 | 85,367 | 81,214 | 81,214 |
| End Cash Position | 38,383 | 61,719 | 102,106 | 85,367 | 43,617 |
| Net Cash Flow | $-46,983 | $-23,648 | $16,739 | $4,152 | $-37,598 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,736 | -4,326 | 10,000 | -64,428 | -54,246 |
| Capital Expenditure | -7,811 | -6,653 | -5,297 | -3,860 | -1,148 |
| Free Cash Flow | -22,546 | -10,979 | 4,704 | -68,288 | -55,394 |